Updated Jul 16, 2026
Dexter Susan is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
Susan Dexter is the Chief Technical Officer and a Director at Sonnet BioTherapeutics Holdings, Inc. She has been involved in multiple SEC filings related to her role in the company.
| Role | Director |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-12-04 | SONN | Sonnet BioTherapeutics Holdings, Inc. | D — Derivative transaction | 9.6K | — | |
| 2025-07-11 | SONN | Sonnet BioTherapeutics Holdings, Inc. | A — Grant or award | 8.0K | — | |
| 2024-12-05 | SONN | Sonnet BioTherapeutics Holdings, Inc. | A — Grant or award | 1.5K | — |
Susan Dexter is the Chief Technical Officer and a Director at Sonnet BioTherapeutics Holdings, Inc. She has been involved in multiple SEC filings related to her role in the company.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Dexter Susan profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.